3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study
Stopped Study was prematurely terminated.
Conditions
Interventions
- DRUG: Previous treatment in DEB025 study
Sponsor
Novartis Pharmaceuticals